Spectral Medical (TSE:EDT) Sets New 52-Week Low – Should You Sell?

by · The Markets Daily

Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) reached a new 52-week low during mid-day trading on Monday. The company traded as low as C$0.98 and last traded at C$1.01, with a volume of 16,918 shares. The stock had previously closed at C$1.00.

Spectral Medical Stock Up 1.0%

The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. The company has a market capitalization of C$296.49 million, a price-to-earnings ratio of -8.42 and a beta of 0.93. The stock’s fifty day moving average price is C$1.21 and its 200-day moving average price is C$1.32.

Spectral Medical Company Profile

(Get Free Report)

Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.

Further Reading